Literature DB >> 16213590

Prevalence of metallo-beta lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India.

Varsha Gupta1, Priya Datta, Jagdish Chander.   

Abstract

OBJECTIVE: Gram-negative bacteria with acquired metallo-beta lactamases production have been increasingly reported in some countries, necessitating their detection. We determined the occurrence of acquired metallo-beta lactamases (MBL) producing bacteria in our teaching hospital.
METHOD: The method employed was a rapid technique using a disk of imipenem plus 750 microg of EDTA, on Mueller-Hinton plate which was supplemented with 70 microg/ml of zinc sulfate, to differentiate MBL producing Pseudomonads and Acinetobacter. RESULT: Out of 200 isolates tested, 7.5% of our Pseudomonads and Acinetobacter were shown to be MBL producers.
CONCLUSIONS: Though MBL prevalence is still low in our hospital set up, screening for MBL among Pseudomonas and Acinetobacter isolates should be routinely done in laboratory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213590     DOI: 10.1016/j.jinf.2005.08.013

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

Review 1.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

2.  Supplementation of growth media with Zn2+ facilitates detection of VIM-2-producing Pseudomonas aeruginosa.

Authors:  Panagiota Giakkoupi; Sofia Vourli; Michalis Polemis; Victoria Kalapothaki; Leonidas S Tzouvelekis; Alkiviadis C Vatopoulos
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

Review 3.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.

Authors:  S Roy; R Viswanathan; A Singh; P Das; S Basu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-21       Impact factor: 3.267

5.  Metallo-β-lactamase-producing clinical isolates from patients of a tertiary care hospital.

Authors:  Durgesh Gopalrao Deshmukh; Ajit S Damle; Jyoti K Bajaj; Jayshree B Bhakre; Neeta S Patwardhan
Journal:  J Lab Physicians       Date:  2011-07

6.  A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A.

Authors:  Dieter Mitteregger; Julian Wessely; Ivan Barišić; Branka Bedenić; Dieter Kosak; Michael Kundi
Journal:  Pathogens       Date:  2022-04-18

7.  Growing Menace of Antibacterial Resistance in Clinical Isolates of Pseudomonas aeruginosa in Nepal: An Insight of Beta-Lactamase Production.

Authors:  Shamshul Ansari; Rabindra Dhital; Sony Shrestha; Sangita Thapa; Ram Puri; Niraj Chaudhary; Suresh Khatiwada; Rajendra Gautam
Journal:  Biomed Res Int       Date:  2016-08-23       Impact factor: 3.411

8.  Emerging threat of multidrug resistant bugs--Acinetobacter calcoaceticus baumannii complex and methicillin resistant Staphylococcus aureus.

Authors:  Shyam Kumar Mishra; Basista Prasad Rijal; Bharat Mani Pokhrel
Journal:  BMC Res Notes       Date:  2013-03-15

9.  Burden of different beta-lactamase classes among clinical isolates of AmpC-producing Pseudomonas aeruginosa in burn patients: A prospective study.

Authors:  V Kumar; M R Sen; C Nigam; R Gahlot; S Kumari
Journal:  Indian J Crit Care Med       Date:  2012-07

10.  Prevalence of metalo- β-lactamase-producing (MBL) Acinetobacter species in a tertiary care hospital.

Authors:  Amarjeet Kaur; Veenu Gupta; Deepinder Chhina
Journal:  Iran J Microbiol       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.